Literature DB >> 17322466

The Amsler chart: absence of evidence is not evidence of absence.

Michael Crossland1, Gary Rubin.   

Abstract

Early detection of the onset or progression of macular disease is likely to become increasingly important as new treatment modalities are introduced. Current best practice involves issuing patients with an Amsler chart for daily or weekly observation with the instruction to attend for immediate assessment should any new distortion be perceived. However the sensitivity of Amsler charts in detecting macular disease can be less than 50%, implying that presentation may be delayed in over half of patients with advancing disease relying on the Amsler chart to detect progression. A likely explanation for this is the phenomenon of perceptual completion whereby regular objects are "filled-in" across the scotoma. Although alternative tests have been developed and shown to have greater sensitivity, at present no straightforward, cheap, home-based test of macular disease progression is available. The development of such a self-diagnostic tool should be a research priority.

Entities:  

Mesh:

Year:  2007        PMID: 17322466      PMCID: PMC1857645          DOI: 10.1136/bjo.2006.095315

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  30 in total

1.  A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler.

Authors:  M F Marmor
Journal:  Surv Ophthalmol       Date:  2000 Jan-Feb       Impact factor: 6.048

2.  Compulsory averaging of crowded orientation signals in human vision.

Authors:  L Parkes; J Lund; A Angelucci; J A Solomon; M Morgan
Journal:  Nat Neurosci       Date:  2001-07       Impact factor: 24.884

3.  Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study.

Authors:  Yair Alster; Neil M Bressler; Susan B Bressler; Judith A Brimacombe; R Michael Crompton; Yi-Jing Duh; Veit-Peter Gabel; Jeffrey S Heier; Michael S Ip; Anat Loewenstein; Kirk H Packo; Michael Stur; Techiya Toaff
Journal:  Ophthalmology       Date:  2005-10       Impact factor: 12.079

4.  Red dots visual field test with blue on yellow & blue on red macula test grid.

Authors:  E Mutlukan
Journal:  Eye (Lond)       Date:  2006-04       Impact factor: 3.775

Review 5.  The neural mechanisms of perceptual filling-in.

Authors:  Hidehiko Komatsu
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

6.  Filling-in of retinal scotomas.

Authors:  Dror Zur; Shimon Ullman
Journal:  Vision Res       Date:  2003-04       Impact factor: 1.886

7.  Preferred retinal locus development in patients with macular disease.

Authors:  Michael D Crossland; Louise E Culham; Stamatina A Kabanarou; Gary S Rubin
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

Review 8.  Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.

Authors:  Andrew A Moshfeghi; Carmen A Puliafito
Journal:  Expert Opin Investig Drugs       Date:  2005-05       Impact factor: 6.206

9.  Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration.

Authors:  Albert J Augustin; I Offermann; J Lutz; Ursula Schmidt-Erfurth; Paul Tornambe
Journal:  Retina       Date:  2005-06       Impact factor: 4.256

10.  Scanning laser entoptic perimetry for the screening of macular and peripheral retinal disease.

Authors:  D J Plummer; S P Azen; W R Freeman
Journal:  Arch Ophthalmol       Date:  2000-09
View more
  22 in total

1.  An elderly lady with blurring of vision.

Authors:  Y Azhany; D Nani; E Zunaina
Journal:  Malays Fam Physician       Date:  2012-04-30

Review 2.  Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis.

Authors:  L Faes; N S Bodmer; L M Bachmann; M A Thiel; M K Schmid
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

3.  Novel quantitative assessment of metamorphopsia in maculopathy.

Authors:  Emily Wiecek; Kameran Lashkari; Steven C Dakin; Peter Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

4.  Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration.

Authors:  Martin K Schmid; Michael A Thiel; Kenny Lienhard; Reinier O Schlingemann; Livia Faes; Lucas M Bachmann
Journal:  Eye (Lond)       Date:  2019-05-01       Impact factor: 3.775

5.  Vision-related quality of life, metamorphopsia, and stereopsis after successful surgery for rhegmatogenous retinal detachment.

Authors:  G Lina; Q Xuemin; W Qinmei; S Lijun
Journal:  Eye (Lond)       Date:  2015-10-02       Impact factor: 3.775

6.  Metamorphopsia and interocular suppression in monocular and binocular maculopathy.

Authors:  Emily Wiecek; Kameran Lashkari; Steven C Dakin; Peter Bex
Journal:  Acta Ophthalmol       Date:  2014-10-01       Impact factor: 3.761

7.  (In) sensitivity to spatial distortion in natural scenes.

Authors:  Peter J Bex
Journal:  J Vis       Date:  2010-02-24       Impact factor: 2.240

8.  Orientation discrimination with macular changes associated with early AMD.

Authors:  Harold E Bedell; Jianliang Tong; Stanley Y Woo; Jon R House; Tammy Nguyen
Journal:  Optom Vis Sci       Date:  2009-05       Impact factor: 1.973

9.  Spatial alignment over retinal scotomas.

Authors:  Michael D Crossland; Peter J Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

10.  Assessment of visual distortions in age-related macular degeneration: emergence of new approaches.

Authors:  Noelia Pitrelli Vazquez; Paul C Knox
Journal:  Br Ir Orthopt J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.